Abstract:Magnetic resonance imaging (MRI), a sophisticated promising three-dimensional tomographic noninvasive diagnostic technique, has an intrinsic advantage in safety compared with radiotracer and optical imaging modalities; however, MRI contrast agents are less sensitive than complexes used in other imaging techniques. Usually the clinically used Gd-based complexes MRI-T1 contrast agents are toxic; therefore, the demand for nontoxic novel T1-weighted MRI candidates with ultrasensitive imaging and advanced functionality is very high. In this research, silica-coated ultra-small monodispersed super-paramagnetic iron oxide nanoparticles were synthesized via a thermal decomposition method, which demonstrated themselves as a high performance T1-weighted MRI contrast agent for heart, liver, kidney and bladder based on in vivo imaging analyses. Transmission electron microscopy (TEM) results illustrated that the diameter of the SPIONPs was in the range of 4 nm and the average size of Fe3O4@SiO2 was about 30-40 nm. X-ray diffraction (XRD) and Raman spectroscopy analyses revealed the phase purity of the prepared SPIONPs. These magnetite nanoparticles exhibited a weak magnetic moment at room temperature because of the spin-canting effect, which promoted a high positive signal enhancement ability. MTT assays and histological analysis demonstrated good biocompatibility of the SPIONPs in vitro and in vivo. In addition, the silica-coated ultra-small (4 nm sized) magnetite nanoparticles exhibited a good r1 relaxivity of 1.2 mM-1 s-1 and a low r2/r1 ratio of 6.5 mM-1 s-1. In vivo T1-weighted MR imaging of heart, liver, kidney and bladder in mice after intravenous injection of nanoparticles further verified the high sensitivity and biocompatibility of the as-synthesized magnetite nanoparticles. These results reveal silica-coated SPIONPs as a promising candidate for a T1 contrast agent with extraordinary capability to enhance MR images.

Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.

Inorganic Nanoparticle-Based T1 and T1/T2 Magnetic Resonance Contrast Probes.

Gadolinium-based contrast agents for tumor targeting imaging

Gadolinium‐based Contrast Agents for Magnetic Resonance Cancer Imaging

Ultrasmall Superparamagnetic Iron Oxide Nanoparticles: A Next Generation Contrast Agent for Magnetic Resonance Imaging

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Surface impact on nanoparticle-based magnetic resonance imaging contrast agents

Superparamagnetic Nanoparticles As High Efficiency Magnetic Resonance Imaging T2 Contrast Agent

Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.

Improving the Magnetic Resonance Imaging Contrast and Detection Methods with Engineered Magnetic Nanoparticles

Rational Design of Magnetic Nanoparticles as T1–T2 Dual-Mode MRI Contrast Agents

Recent Advances in Engineering Iron Oxide Nanoparticles for Effective Magnetic Resonance Imaging.

Magnetic Field-Optimized Paramagnetic Nanoprobe for T2/T1 Switchable Histopathological-Level MRI

Silica-coated Super-Paramagnetic Iron Oxide Nanoparticles (spionps): a New Type Contrast Agent of T1 Magnetic Resonance Imaging (MRI).

Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

Manganese Oxide Nanoparticles As MRI Contrast Agents in Tumor Multimodal Imaging and Therapy

Small is Smarter: Nano MRI Contrast Agents – Advantages and Recent Achievements

Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications

Biomineralized Iron Oxide-Polydopamine Hybrid Nanodots for Contrast-Enhanced T1-weighted Magnetic Resonance Imaging and Photothermal Tumor Ablation.

Stimulus-Responsive Nanoparticle Magnetic Resonance Imaging Contrast Agents: Design Considerations and Applications.

Recent Advances Of Bioresponsive Nano-Sized Contrast Agents For Ultra-High-Field Magnetic Resonance Imaging